J&J faulty hip implant victims demand direct involvement in process of ascertaining compensation

Image
Press Trust of India New Delhi
Last Updated : Sep 15 2018 | 11:35 PM IST

Patients and family members of those affected by Johnson and Johnson's faulty hip implants gathered in Delhi Saturday demanding they be directly involved in the process of ascertaining the compensation.

They asserted the amount should not only be based on the physical, medical criteria but also take into account the mental, social and economic harm faced by them.

They expressed apprehension that the government could "toe the line" of the pharma giant as it was conducting an one-sided inquiry.

The affected patients said the government was jointly liable as it was neither responsive to the safety concerns associated with the device in other countries nor did it take immediate steps to order a mandatory recall and cancel the license of the firm.

Their demands came in the wake of news reports that the central committee being set up for compensation is likely to meet for the first time on September 18.

The AIDAN, a network of patients working with the patients, called for criminal action against all involved, including people in government who failed to act against the use of such harmful implants.

They also responded to claims of Johnson and Johnson that it has been unable to trace the majority of ASR -- anywhere between 2,400 to 3,700 -- because it did not have access to patient details which were only available to surgeons because of confidentiality.

George Thomas, chief orthopaedic surgeon, St Isabel's Hospital in Chennai said, "All joints for human implantation have stickers which are used to trace the individual joint. As per normal protocols, one of these stickers has to be pasted in the surgical record of the patient. Therefore, it is difficult to believe that the patients cannot be found."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 15 2018 | 11:35 PM IST

Next Story